![Avri Havron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Avri Havron
Director/Board Member at
COLLPLANT BIOTECHNOLOGIES LTD.
Net worth: 152 927 $ as of 2026-05-30
Profile
Dr. Abraham Havron is an Independent Director at CollPlant Biotechnologies Ltd. and an Independent Director at Enlivex Therapeutics Ltd. He is on the Board of Directors at CollPlant Ltd., CollPlant Biotechnologies Ltd. and Enlivex Therapeutics Ltd. Dr. Havron was previously employed as an Independent External Director by MediWound Ltd., an Independent Director by Kamada Ltd., a Chief Executive Officer & Director by OPKO Biologics Ltd., a Chief Executive Officer & Director by Prolor Biotech Ltd., a Chief Technology Officer & Vice President by Clal Biotechnology Industries Ltd., a Vice President-Manufacturing & Process Development by Biotechnology General (Israel) Ltd., and a Director-Research & Development by Interpharm Laboratories Ltd. He also served on the board at Pam-Bio Ltd. and Enlivex Therapeutics Ltd. /Old/.
He received his undergraduate degree from The Hebrew University of Jerusalem and a doctorate degree from Weizmann Institute of Science.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ENLIVEX LTD. 0.08% | 2026-03-17 | 183,836 ( 0.08% ) | 148 907 $ | 2026-05-30 |
| 2026-03-17 | 10,000 ( 0.07% ) | 4 020 $ | 2026-05-30 |
Avri Havron active positions
| Companies | Position | Start |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Director/Board Member | 2016-04-30 |
| ENLIVEX LTD. | Director/Board Member | 2013-12-31 |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology Specializes in the development and commercialization of medical products | Director/Board Member | 2016-04-30 |
Former positions of Avri Havron
| Companies | Position | End |
|---|---|---|
Pam-Bio Ltd.
 Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops drug therapy for acute bleeding conditions | Director/Board Member | 2018-12-31 |
| KAMADA LTD. | Director/Board Member | 2018-12-19 |
| MEDIWOUND LTD. | Director/Board Member | 2017-06-21 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Chief Executive Officer | 2012-12-31 |
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Chief Executive Officer | 2012-12-31 |
Training of Avri Havron
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
Clal Biotechnology Industries Ltd.
 Clal Biotechnology Industries Ltd. Financial ConglomeratesFinance Provides investment and support services for life science research companies | Finance |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
MediWound Ltd.
 MediWound Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes bio-therapeutic solutions for tissue repair and regeneration | Health Technology |
CollPlant Ltd.
CollPlant Ltd. BiotechnologyHealth Technology Specializes in the development and commercialization of medical products | Health Technology |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Health Technology |
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
CollPlant Biotechnologies Ltd.
 CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Pam-Bio Ltd.
Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops drug therapy for acute bleeding conditions | Health Technology |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Health Technology |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
- Stock Market
- Insiders
- Avri Havron
